As part of guaranteed free medical care, Kazakhstan will provide children with Hexaxim®, a high-quality European vaccine produced by Sanofi Pasteur, a division of Sanofi, a French pharmaceutical company. According to the National Calendar of Preventive Vaccinations, each child will receive two doses of this vaccine during the first year of life.
Following the negotiations with potential suppliers on reducing the price for the medicine, SC-Pharmacy LLP, the Single Distributor, saved 3 billion 700 million tenge for the national budget and, most importantly, ensured that Kazakhstani children will receive high-quality European vaccines.
Normunds Zemvaldis, General Manager of Sanofi Pasteur, Central Asia and Belarus, said, “Most developed countries use vaccines containing components against hepatitis B, diphtheria, tetanus, pertussis, hemophilia B, poliomyelitis, measles, rubella, mumps, and pneumococcal infection. Obviously, the use of so many monovaccines is not reasonable, therefore, the modern combination vaccines that include several components are used. The use of combination vaccines is currently recommended by WHO. Such vaccines can reduce the costs of immunization and improve the population’s compliance with the vaccination, while expanding the immunization programs for children.”